Envestnet Asset Management
IOVA icon

Envestnet Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History

Envestnet Asset Management’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,209
Closed -$52.4K – 4771
2025
Q4 		$52.4K Sell
19,209
-43,839
-70% -$101K ﹤0.01% 4414
2025
Q3 		$137K Buy
63,048
+15,582
+33% +$36.8K ﹤0.01% 4387
2025
Q2 		$81.6K Buy
47,466
+25,083
+112% +$62.4K ﹤0.01% 4359
2025
Q1 		$74.5K Sell
22,383
-5,548
-20% -$28.6K ﹤0.01% 4268
2024
Q4 		$207K Sell
27,931
-1,446
-5% -$13.4K ﹤0.01% 4083
2024
Q3 		$276K Buy
29,377
+3,584
+14% +$34K ﹤0.01% 3872
2024
Q2 		$207K Sell
25,793
-5,575
-18% -$59.7K ﹤0.01% 3917
2024
Q1 		$465K Buy
31,368
+6,957
+28% +$81K ﹤0.01% 3487
2023
Q4 		$198K Sell
24,411
-367
-1% -$1.92K ﹤0.01% 3829
2023
Q3 		$113K Buy
24,778
+5,796
+31% +$37.8K ﹤0.01% 3853
2023
Q2 		$134K Sell
18,982
-3,773
-17% -$27K ﹤0.01% 3795
2023
Q1 		$139K Buy
+22,755
New +$157K ﹤0.01% 3737
2022
Q2 		– Sell
-14,017
Closed -$233K – 3984
2022
Q1 		$233K Buy
14,017
+2,099
+18% +$32.5K ﹤0.01% 3598
2021
Q4 		$228K Buy
11,918
+64
+0.5% +$1.41K ﹤0.01% 3586
2021
Q3 		$292K Sell
11,854
-890
-7% -$21K ﹤0.01% 3307
2021
Q2 		$332K Sell
12,744
-656
-5% -$17.1K ﹤0.01% 3230
2021
Q1 		$424K Buy
13,400
+8
+0.1% +$332 ﹤0.01% 2942
2020
Q4 		$621K Sell
13,392
-1,220
-8% -$48.4K ﹤0.01% 2541
2020
Q3 		$481K Buy
14,612
+1,587
+12% +$48.7K ﹤0.01% 2485
2020
Q2 		$358K Buy
13,025
+1,817
+16% +$59.7K ﹤0.01% 2597
2020
Q1 		$336K Buy
+11,208
New +$297K ﹤0.01% 2498

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Envestnet Asset Management's IOVA Position: Q1 2026 in Review

Envestnet Asset Management sold out of Iovance Biotherapeutics (IOVA) in Q1 2026, closing a stake of 19,209 shares — an estimated $52.4K sold.

Envestnet Asset Management first reported a position in IOVA in Q1 2020 and held it in 21 quarters. The position peaked at $621K in Q4 2020. 286 funds tracked by Wall St. Rank hold IOVA as of Q1 2026.

  • Envestnet Asset Management reported no remaining Iovance Biotherapeutics position as of Q1 2026 after selling out during the quarter.
  • Envestnet Asset Management sold 19,209 Iovance Biotherapeutics shares in Q1 2026, an estimated $52.4K.
  • Envestnet Asset Management first reported a position in Iovance Biotherapeutics in Q1 2020 and held it in 21 quarters.
  • Envestnet Asset Management's Iovance Biotherapeutics position peaked at $621K in Q4 2020.
  • 286 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2026.

Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.